First-in-class, first-in-human phase I results of targeted agents: Highlights of the 2008 American Society of Clinical Oncology meeting

por Molckovsky, Andrea, Siu, Lillian L
Publicado 2008

Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment

por Brana, Irene, Siu, Lillian L
Publicado 2012

Approaches to modernize the combination drug development paradigm

por Day, Daphne, Siu, Lillian L.
Publicado 2016

Precision Medicine in Head and Neck Cancer: Myth or Reality?

por Malone, Eoghan, Siu, Lillian L
Publicado 2018

Genomically personalized therapy in head and neck cancer

por Aung, Kyaw L., Siu, Lillian L.
Publicado 2016

Increasing operational and scientific efficiency in clinical trials

por Kelly, Deirdre, Spreafico, Anna, Siu, Lillian L.
Publicado 2020

Dose Escalation Methods in Phase I Cancer Clinical Trials

por Le Tourneau, Christophe, Lee, J. Jack, Siu, Lillian L.
Publicado 2009

Hepatic steatosis secondary to capecitabine: a case report

por Chin, Sheray N, Kim, Tae K, Siu, Lillian L
Publicado 2010

Designing circulating tumor DNA-based interventional clinical trials in oncology

por Araujo, Daniel V., Bratman, Scott V., Siu, Lillian L.
Publicado 2019

Circulating Biomarkers for Therapeutic Monitoring of Anti-cancer Agents

por Janse van Rensburg, Helena J, Spiliopoulou, Pavlina, Siu, Lillian L
Publicado 2022

Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges

por Sanz-Garcia, Enrique, Zhao, Eric, Bratman, Scott V., Siu, Lillian L.
Publicado 2022

Molecular profiling for precision cancer therapies

por Malone, Eoghan R., Oliva, Marc, Sabatini, Peter J. B., Stockley, Tracy L., Siu, Lillian L.
Publicado 2020

Understanding the attitudes of the elderly towards enrolment into cancer clinical trials

por Townsley, Carol A, Chan, Kelvin K, Pond, Gregory R, Marquez, Christine, Siu, Lillian L, Straus, Sharon E
Publicado 2006

Testing ERBB2 p.L755S kinase domain mutation as a druggable target in a patient with advanced colorectal cancer

por Aung, Kyaw L., Stockley, Tracy L., Serra, Stefano, Kamel-Reid, Suzanne, Bedard, Philippe L., Siu, Lillian L.
Publicado 2016

Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital

por Ho, Jeremy, Pond, Gregory R, Newman, Colin, Maclean, Martha, Chen, Eric X, Oza, Amit M, Siu, Lillian L
Publicado 2006

Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection?

por Chau, Nicole G, Florescu, Ana, Chan, Kelvin K, Wang, Lisa, Chen, Eric X, Bedard, Philippe, Oza, Amit M, Siu, Lillian L
Publicado 2011

Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study

por Kotasek, Dusan, Tebbutt, Niall, Desai, Jayesh, Welch, Stephen, Siu, Lillian L, McCoy, Sheryl, Sun, Yu-Nien, Johnson, Jessica, Adewoye, Adeboye H, Price, Timothy
Publicado 2011

Two-Target Quantitative PCR To Predict Library Composition for Shallow Shotgun Sequencing

por Cho, Matthew Y., Oliva, Marc, Spreafico, Anna, Chen, Bo, Wei, Xu, Choi, Yoojin, Kaul, Rupert, Siu, Lillian L., Coburn, Bryan, Schneeberger, Pierre H. H.
Publicado 2021

HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA

por Leung, Eric, Han, Kathy, Zou, Jinfeng, Zhao, Zhen, Zheng, Yangqiao, Wang, Ting Ting, Rostami, Ariana, Siu, Lillian L., Pugh, Trevor J., Bratman, Scott V.
Publicado 2021

Pre-Clinical Characterization of Dacomitinib (PF-00299804), an Irreversible Pan-ErbB Inhibitor, Combined with Ionizing Radiation for Head and Neck Squamous Cell Carcinoma

por Williams, Justin P., Kim, Inki, Ito, Emma, Shi, Wei, Yue, Shijun, Siu, Lillian L., Waldron, John, O'Sullivan, Brian, Yip, Kenneth W., Liu, Fei-Fei
Publicado 2014